$Histogenics(OCGN)$At this point, seeing @InvestorPlace articles with neanderthal-bred titles like "Ocugen's Vaccine is Too Little, Too Late"

Should really just give long-holders more confidence.

Covaxin is the only vaccine to have solid data of its efficacy vs the Delta strain.

Moreover, that efficacy, according to the head scientist of the WHO appears to be 70%. That's ~5% higher than the 65.7% Bharat reported in their interim results.

Meanwhile we have data from Israel back at the end of summer that showed Pfizer's efficacy drop down as low as 30% in Israel during Delta's surge there.

But yeah... "Too Little, Too Late"

Should really be "Far Superior, Just On Time"